STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Tables)
|
3 Months Ended |
12 Months Ended |
Mar. 31, 2026 |
Dec. 31, 2025 |
| Equity [Abstract] |
|
|
| Schedule of stock options |
|
| Schedule of stock options | | |
| | | |
| | | |
| | | |
| | |
| | | |
Options Outstanding | |
| | | |
| | | |
| | | |
| Weighted - | | |
| | |
| | | |
| | | |
| | | |
| Average | | |
| | |
| | | |
| | | |
| | | |
| Remaining | | |
| Aggregate | |
| | | |
| | | |
| Weighted- | | |
| Contractual | | |
| Intrinsic | |
| | | |
| Number of | | |
| Average | | |
| Term | | |
| Value | |
| | | |
| Shares | | |
| Exercise Price | | |
| (in years) | | |
| (in thousands)(1) | |
| Balance as of December 31, 2023 | | |
| 301,471 | | |
$ | 4.56 | | |
| | | |
| | |
| | | |
| | | |
| | | |
| | | |
| | |
| Granted | | |
| - | | |
| - | | |
| | | |
| | |
| | | |
| | | |
| | | |
| | | |
| | |
| Forfeited/Cancelled/Expired | | |
| (80,471 | ) | |
| 7.27 | | |
| | | |
| | |
| | | |
| | | |
| | | |
| | | |
| | |
| Balance as of December 31, 2024 | | |
| 221,000 | | |
| 3.57 | | |
| 0.4 | | |
| - | |
| | | |
| | | |
| | | |
| | | |
| | |
| Exercisable as of December 31, 2024 | | |
| 221,000 | | |
$ | 3.57 | | |
| 0.4 | | |
$ | - | |
| | | |
| | | |
| | | |
| | | |
| | |
| Granted | | |
| - | | |
| - | | |
| | | |
| | |
| | | |
| | | |
| | | |
| | | |
| | |
| Forfeited/Cancelled/Expired | | |
| (221,000 | ) | |
| 3.57 | | |
| | | |
| | |
| | | |
| | | |
| | | |
| | | |
| | |
| Balance as of December 31, 2025 | | |
| - | | |
| - | | |
| - | | |
| - | |
| | | |
| | | |
| | | |
| | | |
| | |
| Exercisable as of December 31, 2025 | | |
| - | | |
$ | - | | |
| - | | |
$ | - | |
| (1) | The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying
awards and the quoted price of the Company’s common stock for options that were in-the-money at each respective period. |
|
| Schedule of unvested options |
|
| Schedule of unvested options | | |
| | | |
| | |
| | | |
| | |
Weighted - | |
| | | |
| | |
Average | |
| | | |
Number of | | |
Grant | |
| | | |
Award Shares | | |
Date Fair Value | |
| | | |
| | |
| |
| Unvested at December 31, 2023 | | |
| 416,669 | | |
| 1.44 | |
| | | |
| | | |
| | |
| Granted | | |
| 140,000 | | |
| 1.60 | |
| | | |
| | | |
| | |
| Vested | | |
| (416,669 | ) | |
| 1.44 | |
| | | |
| | | |
| | |
| Balance at December 31, 2024 | | |
| 140,000 | | |
| 1.60 | |
| | | |
| | | |
| | |
| Granted | | |
| 70,000 | | |
| 1.04 | |
| | | |
| | | |
| | |
| Vested | | |
| (140,000 | ) | |
| 1.60 | |
| | | |
| | | |
| | |
| Balance at December 31, 2025 | | |
| 70,000 | | |
$ | 1.04 | |
|
| Schedule of unvested restricted stock awards |
| Schedule of unvested restricted stock awards |
|
|
|
|
|
|
|
|
| |
|
|
|
|
Weighted - |
|
| |
|
|
|
|
Average |
|
| |
|
Number of |
|
|
Grant |
|
| |
|
Award Shares |
|
|
Date Fair Value |
|
| |
|
|
|
|
|
|
| Unvested at December 31, 2025 |
|
|
70,000 |
|
|
$ |
1.04 |
|
| |
|
|
|
|
|
|
|
|
| Granted |
|
|
- |
|
|
|
- |
|
| |
|
|
|
|
|
|
|
|
| Vested |
|
|
- |
|
|
|
- |
|
| |
|
|
|
|
|
|
|
|
| Forfeited |
|
|
- |
|
|
|
- |
|
| |
|
|
|
|
|
|
|
|
| Balance at March 31, 2026 |
|
|
70,000 |
|
|
$ |
1.04 |
|
|
| Schedule of unvested restricted stock awards | | |
| | | |
| | |
| | | |
Unvested Restricted Stock Units | |
| | | |
| | | |
| Weighted - | |
| | | |
| | | |
| Average | |
| | | |
| Number of | | |
| Grant | |
| | | |
| Unit Shares | | |
| Date Fair Value | |
| Unvested at December 31, 2023 | | |
| 371,253 | | |
| 1.32 | |
| | | |
| | | |
| | |
| Granted | | |
| 88,011 | | |
| 1.46 | |
| | | |
| | | |
| | |
| Vested | | |
| (160,194 | ) | |
| 1.31 | |
| | | |
| | | |
| | |
| Forfeit/Cancelled | | |
| (25,334 | ) | |
| 1.23 | |
| | | |
| | | |
| | |
| Unvested at December 31, 2024 | | |
| 273,736 | | |
| 1.38 | |
| | | |
| | | |
| | |
| Granted | | |
| 180,773 | | |
| 1.34 | |
| | | |
| | | |
| | |
| Vested | | |
| (201,374 | ) | |
| 1.39 | |
| | | |
| | | |
| | |
| Forfeited/Cancelled | | |
| (20,334 | ) | |
| 1.57 | |
| | | |
| | | |
| | |
| Balance at December 31, 2025 | | |
| 232,801 | | |
$ | 1.32 | |
|
| Schedule of unvested restricted stock units |
| Schedule of unvested restricted stock units |
|
|
|
|
|
|
|
|
| |
|
|
|
|
Weighted - |
|
| |
|
|
|
|
Average |
|
| |
|
Number of |
|
|
Grant |
|
| |
|
Unit Shares |
|
|
Date Fair Value |
|
| Unvested at December 31, 2025 |
|
|
232,801 |
|
|
$ |
1.32 |
|
| |
|
|
|
|
|
|
|
|
| Granted |
|
|
- |
|
|
|
- |
|
| |
|
|
|
|
|
|
|
|
| Vested |
|
|
(70,773 |
) |
|
|
1.70 |
|
| |
|
|
|
|
|
|
|
|
| Forfeited |
|
|
- |
|
|
|
- |
|
| |
|
|
|
|
|
|
|
|
| Balance at March 31, 2026 |
|
|
162,028 |
|
|
$ |
1.13 |
|
|
| Schedule of unvested restricted stock units | | |
| | | |
| | |
| | | |
Unvested Performance
Restricted | |
| | | |
Stock Units | |
| | | |
| | | |
| Weighted - | |
| | | |
| | | |
| Average | |
| | | |
| Number of | | |
| Grant | |
| | | |
| Unit Shares | | |
| Date Fair Value | |
| Unvested at December 31, 2023 | | |
| 1,438,760 | | |
| 1.51 | |
| | | |
| | | |
| | |
| Granted | | |
| 555,000 | | |
| 1.08 | |
| | | |
| | | |
| | |
| Vested | | |
| - | | |
| - | |
| | | |
| | | |
| | |
| Forfeited/Cancelled | | |
| (387,100 | ) | |
| 1.47 | |
| | | |
| | | |
| | |
| Balance at December 31, 2024 | | |
| 1,606,660 | | |
| 1.37 | |
| | | |
| | | |
| | |
| Granted | | |
| - | | |
| - | |
| | | |
| | | |
| | |
| Vested | | |
| - | | |
| - | |
| | | |
| | | |
| | |
| Forfeited/Cancelled | | |
| (285,069 | ) | |
| 2.40 | |
| | | |
| | | |
| | |
| Balance at December 31, 2025 | | |
| 1,321,591 | | |
$ | 1.15 | |
|
| Schedule of warrants outstanding |
| Schedule of warrants outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Number of
Warrant Shares |
|
|
Weighted-
Average
Exercise
Price |
|
|
Weighted -
Average
Remaining
Contractual
Term
(in years) |
|
|
Aggregate
Intrinsic
Value
(in thousands)(1) |
|
| Balance as of December 31, 2025 |
|
|
1,555,207 |
|
|
|
3.95 |
|
|
|
4.4 |
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issued |
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercised |
|
|
|
- |
|
|
- |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Expired |
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Balance as of March 31, 2026 |
|
|
1,555,207 |
|
|
$ |
3.95 |
|
|
|
4.1 |
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercisable as of March 31, 2026 |
|
|
1,555,207 |
|
|
$ |
3.95 |
|
|
|
4.1 |
|
|
$ |
- |
|
| (1) | The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying
warrants and the closing stock price of $0.81 for our common stock on March 31, 2026. |
|
| Schedule of warrants outstanding | |
| | | |
| | | |
| | | |
| | |
| | |
Warrants Outstanding (Excluding Pre-Funded Warrants) | |
| | |
| Number of Warrant
Shares | | |
| Weighted- Average Exercise Price | | |
| Weighted - Average Remaining Contractual Term in years) | | |
| Aggregate Intrinsic Value (in thousands)(1) | |
| Balance at December 31, 2023 | |
| 4,628,586 | | |
$ | 4.13 | | |
| | | |
| | |
| | |
| | | |
| | | |
| | | |
| | |
| Granted | |
| - | | |
| - | | |
| | | |
| | |
| | |
| | | |
| | | |
| | | |
| | |
| Expired | |
| - | | |
| - | | |
| | | |
| | |
| | |
| | | |
| | | |
| | | |
| | |
| Balance at December 31, 2024 | |
| 4,628,586 | | |
| 4.13 | | |
| | | |
| | |
| | |
| | | |
| | | |
| | | |
| | |
| Granted | |
| 1,461,896 | | |
| 4.00 | | |
| | | |
| | |
| | |
| | | |
| | | |
| | | |
| | |
| Exercised | |
| (1,461,896 | ) | |
| 3.22 | | |
| | | |
| | |
| | |
| | | |
| | | |
| | | |
| | |
| Expired | |
| (3,073,379 | ) | |
| 4.60 | | |
| | | |
| | |
| | |
| | | |
| | | |
| | | |
| | |
| Balance at December 31, 2025 | |
| 1,555,207 | | |
| 3.95 | | |
| 4.4 | | |
| | |
| | |
| | | |
| | | |
| | | |
| | |
| Exercisable at December 31, 2025 | |
| 1,555,207 | | |
| 3.95 | | |
| 4.4 | | |
$ | - | |
| (1) | The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying
warrants and the closing stock price of $0.60 for our common stock on December 31, 2025. |
|
| Schedule of assumptions |
|
| Schedule of assumptions | |
| | |
| | |
January 13, 2025 | |
| Risk free interest rate | |
| 4.34 | % |
| Expected life | |
| 2.75 years | |
| Expected volatility | |
| 171 | % |
| Expected dividend | |
| - | |
|